Literature DB >> 11916963

Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity.

Boopathy Ramakrishnan1, Pradman K Qasba.   

Abstract

beta1,4-Galactosyltransferase I (Gal-T1) normally transfers Gal from UDP-Gal to GlcNAc in the presence of Mn(2+) ion. In the presence of alpha-lactalbumin (LA), the Gal acceptor specificity is altered from GlcNAc to Glc. Gal-T1 also transfers GalNAc from UDP-GalNAc to GlcNAc, but with only approximately 0.1% of Gal-T activity. To understand this low GalNAc-transferase activity, we have carried out the crystal structure analysis of the Gal-T1.LA complex with UDP-GalNAc at 2.1-A resolution. The crystal structure reveals that the UDP-GalNAc binding to Gal-T1 is similar to the binding of UDP-Gal to Gal-T1, except for an additional hydrogen bond formed between the N-acetyl group of GalNAc moiety with the Tyr-289 side chain hydroxyl group. Elimination of this additional hydrogen bond by mutating Tyr-289 residue to Leu, Ile, or Asn enhances the GalNAc-transferase activity. Although all three mutants exhibit enhanced GalNAc-transferase activity, the mutant Y289L exhibits GalNAc-transferase activity that is nearly 100% of its Gal-T activity, even while completely retaining its Gal-T activity. The steady state kinetic analyses on the Leu-289 mutant indicate that the K(m) for GlcNAc has increased compared to the wild type. On the other hand, the catalytic constant (k(cat)) in the Gal-T reaction is comparable with the wild type, whereas it is 3-5-fold higher in the GalNAc-T reaction. Interestingly, in the presence of LA, these mutants also transfer GalNAc to Glc instead of to GlcNAc. The present study demonstrates that, in the Gal-T family, the Tyr-289/Phe-289 residue largely determines the sugar donor specificity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916963     DOI: 10.1074/jbc.M111183200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 2.  Glycosyltransferase engineering for carbohydrate synthesis.

Authors:  John B McArthur; Xi Chen
Journal:  Biochem Soc Trans       Date:  2016-02       Impact factor: 5.407

Review 3.  Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI.

Authors:  Boopathy Ramakrishnan; Elizabeth Boeggeman; Pradman K Qasba
Journal:  Expert Opin Drug Deliv       Date:  2008-02       Impact factor: 6.648

Review 4.  Chemical approaches to understanding O-GlcNAc glycosylation in the brain.

Authors:  Jessica E Rexach; Peter M Clark; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2008-02       Impact factor: 15.040

5.  Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection.

Authors:  Elizabeth Boeggeman; Boopathy Ramakrishnan; Marta Pasek; Maria Manzoni; Anu Puri; Kristin H Loomis; Timothy J Waybright; Pradman K Qasba
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

6.  Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.

Authors:  Brendon E Cook; Pierre Adumeau; Rosemery Membreno; Kathryn E Carnazza; Christian Brand; Thomas Reiner; Brian J Agnew; Jason S Lewis; Brian M Zeglis
Journal:  Bioconjug Chem       Date:  2016-07-14       Impact factor: 4.774

7.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

Review 8.  Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI.

Authors:  Pradman K Qasba; Boopathy Ramakrishnan; Elizabeth Boeggeman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface.

Authors:  Natalia Mercer; Boopathy Ramakrishnan; Elizabeth Boeggeman; Luke Verdi; Pradman K Qasba
Journal:  Bioconjug Chem       Date:  2013-01-03       Impact factor: 4.774

10.  Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes.

Authors:  Zihao Wang; Kyoungsook Park; Frank Comer; Linda C Hsieh-Wilson; Christopher D Saudek; Gerald W Hart
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.